445 related articles for article (PubMed ID: 31794690)
1. Susceptibility of Nitrofurantoin and Fosfomycin Against Outpatient Urinary Isolates of Multidrug-Resistant Enterococci over a Period of 10 Years from India.
Das A; Banerjee T; Anupurba S
Microb Drug Resist; 2020 Dec; 26(12):1509-1515. PubMed ID: 31794690
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility of enterococci strains isolated from urine samples to fosfomycin and other antibiotics.
Butcu M; Akcay SS; Inan AS; Aksaray S; Engin DO; Calisici G
J Infect Chemother; 2011 Aug; 17(4):575-8. PubMed ID: 21287226
[TBL] [Abstract][Full Text] [Related]
3. In vitro efficacy of fosfomycin-based combinations against clinical vancomycin-resistant Enterococcus isolates.
Tang HJ; Chen CC; Zhang CC; Su BA; Li CM; Weng TC; Chiang SR; Ko WC; Chuang YC
Diagn Microbiol Infect Dis; 2013 Nov; 77(3):254-7. PubMed ID: 24029433
[TBL] [Abstract][Full Text] [Related]
4. In vitro susceptibility of vancomycin-resistant enterococci (VRE) to fosfomycin.
Perri MB; Hershberger E; Ionescu M; Lauter C; Zervos MJ
Diagn Microbiol Infect Dis; 2002 Apr; 42(4):269-71. PubMed ID: 12007445
[TBL] [Abstract][Full Text] [Related]
5. Oral Fosfomycin Treatment for Enterococcal Urinary Tract Infections in a Dynamic
Abbott IJ; van Gorp E; van der Meijden A; Wijma RA; Meletiadis J; Roberts JA; Mouton JW; Peleg AY
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32253214
[TBL] [Abstract][Full Text] [Related]
6. Phenotypic and genotypic study of biofilm formation in Enterococci isolated from urinary tract infections.
Fallah F; Yousefi M; Pourmand MR; Hashemi A; Nazari Alam A; Afshar D
Microb Pathog; 2017 Jul; 108():85-90. PubMed ID: 28483600
[TBL] [Abstract][Full Text] [Related]
7. Biofilm synthesis and other virulence factors in multidrug-resistant uropathogenic enterococci isolated in Northern India.
Das AK; Dudeja M; Kohli S; Ray P; Singh M; Kaur PS
Indian J Med Microbiol; 2020; 38(2):200-209. PubMed ID: 32883934
[TBL] [Abstract][Full Text] [Related]
8. Characterization of clinical enterococci isolates, focusing on the vancomycin-resistant enterococci in a tertiary hospital in China: based on the data from 2013 to 2018.
Zhou W; Zhou H; Sun Y; Gao S; Zhang Y; Cao X; Zhang Z; Shen H; Zhang C
BMC Infect Dis; 2020 May; 20(1):356. PubMed ID: 32517758
[TBL] [Abstract][Full Text] [Related]
9. Molecular Epidemiology of Vancomycin-Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Clinical Specimens in the Northwest of Iran.
Jahansepas A; Ahangarzadeh Rezaee M; Hasani A; Sharifi Y; Rahnamaye Farzami M; Dolatyar A; Aghazadeh M
Microb Drug Resist; 2018 Oct; 24(8):1165-1173. PubMed ID: 29708837
[TBL] [Abstract][Full Text] [Related]
10. [Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].
Rudy M; Nowakowska M; WiechuĊa B; Zientara M; Radosz-Komoniewska H
Przegl Lek; 2004; 61(5):473-6. PubMed ID: 15515808
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of nitrofurantoin in enterococcus urinary tract infection.
Butt T; Leghari MJ; Mahmood A
J Pak Med Assoc; 2004 Sep; 54(9):466-9. PubMed ID: 15518369
[TBL] [Abstract][Full Text] [Related]
12. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.
Kramer TS; Remschmidt C; Werner S; Behnke M; Schwab F; Werner G; Gastmeier P; Leistner R
Antimicrob Resist Infect Control; 2018; 7():133. PubMed ID: 30459945
[TBL] [Abstract][Full Text] [Related]
13. Urinary tract infection caused by Enterococcus isolates: aetiology and antimicrobial resistance patterns.
Wang QY; Li RH; Shang XH
J Chemother; 2015 Feb; 27(2):117-9. PubMed ID: 24835052
[TBL] [Abstract][Full Text] [Related]
14. High incidence of virulence determinants, aminoglycoside and vancomycin resistance in enterococci isolated from hospitalized patients in Northwest Iran.
Haghi F; Lohrasbi V; Zeighami H
BMC Infect Dis; 2019 Aug; 19(1):744. PubMed ID: 31455296
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium: potential utility of fosfomycin.
Shrestha NK; Chua JD; Tuohy MJ; Wilson DA; Procop GW; Longworth DL; Isada CM; Hall GS
Scand J Infect Dis; 2003; 35(1):12-4. PubMed ID: 12685877
[TBL] [Abstract][Full Text] [Related]
16. Fosfomycin synergy in vitro with amoxicillin, daptomycin, and linezolid against vancomycin-resistant Enterococcus faecium from renal transplant patients with infected urinary stents.
Descourouez JL; Jorgenson MR; Wergin JE; Rose WE
Antimicrob Agents Chemother; 2013 Mar; 57(3):1518-20. PubMed ID: 23263002
[TBL] [Abstract][Full Text] [Related]
17. Emergence of High-level Gentamicin Resistance among
Labibzadeh M; Kaydani GA; Savari M; Ekrami A
Pol J Microbiol; 2018; 67(4):401-406. PubMed ID: 30550226
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS).
Zhanel GG; Laing NM; Nichol KA; Palatnick LP; Noreddin A; Hisanaga T; Johnson JL; Hoban DJ;
J Antimicrob Chemother; 2003 Sep; 52(3):382-8. PubMed ID: 12888592
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
Barber KE; Smith JR; Raut A; Rybak MJ
J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial resistance profile of Enterococcus species isolated from intestinal tracts of hospitalized patients in Jimma, Ethiopia.
Abamecha A; Wondafrash B; Abdissa A
BMC Res Notes; 2015 Jun; 8():213. PubMed ID: 26036911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
